BackLakeShore Biopharma Co Overview

LakeShore Biopharma Co Selling, General & Admin

See how YS's SG&A expenses trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$62.60M

As of Mar 31, 2024

Annual SG&A Expenses (TTM)

$437.78M

Trailing 12 months ending Mar 31, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

LakeShore Biopharma Co (YS) FAQ

Stockcircle tracks selling, general & admin for LakeShore Biopharma Co (YS), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for LakeShore Biopharma Co's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main YS overview so you can move from this figure to the surrounding analysis quickly.